Clinical Trial Detail

NCT ID NCT02448810
Title Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Baxalta US Inc.
Indications

colorectal cancer

Therapies

Fluorouracil + Leucovorin

Imalumab

Panitumumab

Age Groups: adult

No variant requirements are available.